Divis Laboratories Quarterly Results - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

Divis Laboratories Quarterly Results    (DIVI)

Here are the latest quarterly results of Divis Laboratories. For more details, see the Divis Laboratories financial fact sheet and Divis Laboratories share price and chart. For a sector overview, read our pharmaceuticals sector report.

Excel Export | Annual Financial Info | Result Scoreboard

Divis Laboratories Quarterly Results

No. of Mths
Qtr. Ending
3
Mar-19
3
Jun-19
3
Sep-19
3
Dec-19
3
Mar-20
3
Jun-20
3
Sep-20
3
Dec-20
8-Qtr Chart
Click to enlarge
Net Sales Rs m12,56411,39914,45613,90513,76217,10017,13816,565 
Other income Rs m417316470403765179136197 
Turnover Rs m12,98211,71614,92614,30814,52817,27817,27416,762 
Expenses Rs m8,4537,6139,5508,9369,27610,1109,8149,780 
Gross profit Rs m4,1113,7864,9064,9694,4866,9907,3246,785 
Depreciation Rs m423438459467495560609680 
Interest Rs m1338164212 
Profit before tax Rs m4,1043,6614,8794,8894,7526,6076,8506,300 
Tax Rs m1,2109881,3111,2828341,6851,7171,687 
Profit after tax Rs m2,8942,6743,5683,6073,9184,9235,1334,612 
Gross profit margin %32.733.233.935.732.640.942.741.0 
Effective tax rate %29.527.026.926.217.625.525.126.8 
Net profit margin %23.023.524.725.928.528.830.027.8 
Diluted EPS Rs 10.9 10.1 13.4 13.6 14.8 18.5 19.3 17.4  
Diluted EPS (TTM) Rs 50.2 50.2 48.7 48.0 51.9 60.3 66.2 70.0  
 Subscriber Feature                  
* Results Consolidated
Interim results exclude extraordinary / exceptional items
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Read: Divis Laboratories 3QFY21 Result Performance Review

More Pharmaceuticals Company Quarterly Results:   FRESENIUS KABI ONCO.  DR. REDDYS LAB  ALEMBIC  IPCA LABS  DISHMAN PHARMA  

Compare DIVIS LABORATORIES With:   FRESENIUS KABI ONCO.  DR. REDDYS LAB  ALEMBIC  IPCA LABS  DISHMAN PHARMA  

Compare DIVIS LABORATORIES With:   ADCOCK INGRAM (S. Africa)  MYLAN (US)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Wipro's Biggest Acquisition, Vodafone Idea Fundraising Plan, and Buzzing Stocks Today(Pre-Open)

Indian share markets witnessed huge selling during closing hours on Friday and ended lower.

Views on news

DIVIS LABORATORIES Announces Quarterly Results (3QFY21); Net Profit Up 27.9% (Quarterly Result Update)

Feb 10, 2021 | Updated on Feb 10, 2021

For the quarter ended December 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 27.9% YoY). Sales on the other hand came in at Rs 17 bn (up 19.1% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES Announces Quarterly Results (1QFY21); Net Profit Up 84.1% (Quarterly Result Update)

Aug 10, 2020 | Updated on Aug 10, 2020

For the quarter ended June 2020, DIVIS LABORATORIES has posted a net profit of Rs 5 bn (up 84.1% YoY). Sales on the other hand came in at Rs 17 bn (up 50.0% YoY). Read on for a complete analysis of DIVIS LABORATORIES's quarterly results.

DIVIS LABORATORIES 2018-19 Annual Report Analysis (Annual Result Update)

Oct 10, 2019 | Updated on Oct 10, 2019

Here's an analysis of the annual report of DIVIS LABORATORIES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of DIVIS LABORATORIES. Also includes updates on the valuation of DIVIS LABORATORIES.

More Views on News

Most Popular

It's the Beginning of a New Bull Phase in Smallcaps (Profit Hunter)

Feb 24, 2021

Last time the smallcap index crossed 19k a big correction followed. Here's what makes it different this time.

Make Rs 5,000 Per Day Trading the Market (Fast Profits Daily)

Feb 25, 2021

In this video, I'll show you how to get started on the path to daily trading profits.

The Hidden Tesla in My Great Indian Wealth Project (Profit Hunter)

Feb 23, 2021

An Indian company founded three decades ago in a garage caught my attention...

Gold 65,000 and Silver 84,000 in 2022

Feb 26, 2021

In this episode of the Investor Hour, India's #1 trader, Vijay Bhambwani, talks to us about the stock market, his new targets for gold and silver, the best long-term investment opportunity, and a lot more.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DIVIS LABORATORIES SHARE PRICE


Mar 5, 2021 (Close)

TRACK DIVIS LABORATORIES

  • Track your investment in DIVIS LABORATORIES with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DIVIS LABORATORIES

DIVIS LABORATORIES - FRESENIUS KABI ONCO. COMPARISON

COMPARE DIVIS LABORATORIES WITH

MARKET STATS